BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 28537702)

  • 1. The awareness of patients with non - muscle invasive bladder cancer regarding the importance of smoking cessation and their access to smoking cessation programs.
    Yuruk E; Tuken M; Colakerol A; Serefoglu EC
    Int Braz J Urol; 2017; 43(4):607-614. PubMed ID: 28537702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of smoking and timing of smoking cessation on clinical outcome in non-muscle-invasive bladder cancer.
    Grotenhuis AJ; Ebben CW; Aben KK; Witjes JA; Vrieling A; Vermeulen SH; Kiemeney LA
    Urol Oncol; 2015 Feb; 33(2):65.e9-17. PubMed ID: 25023787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between smoking cessation before and after diagnosis and non-muscle-invasive bladder cancer recurrence: a prospective cohort study.
    van Osch FHM; Jochems SHJ; Reulen RC; Pirrie SJ; Nekeman D; Wesselius A; James ND; Wallace DMA; Cheng KK; van Schooten FJ; Bryan RT; Zeegers MP
    Cancer Causes Control; 2018 Jul; 29(7):675-683. PubMed ID: 29846846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refraining from Smoking for 15 Years or More Reduced the Risk of Tumor Recurrence in Non-muscle Invasive Bladder Cancer Patients.
    Ogihara K; Kikuchi E; Yuge K; Ito Y; Tanaka N; Matsumoto K; Miyajima A; Asakura H; Oya M
    Ann Surg Oncol; 2016 May; 23(5):1752-9. PubMed ID: 26671037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does Smoking Cessation at Primary Diagnosis Reduce the Recurrence Risk of Nonmuscle-Invasive Bladder Cancer? Results of a Prospective Study.
    Serretta V; Di Maida F; Baiamonte D; Vella M; Pavone C; Cacciatore L; Valerio MR; Scalici Gesolfo C; Sanfilippo C
    Urol Int; 2020; 104(5-6):396-401. PubMed ID: 32369816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of smoking status and cumulative smoking exposure on tumor recurrence of non-muscle-invasive bladder cancer.
    Li HM; Azhati B; Rexiati M; Wang WG; Li XD; Liu Q; Wang YJ
    Int Urol Nephrol; 2017 Jan; 49(1):69-76. PubMed ID: 27766490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smoking knowledge assessment and cessation trends in patients with bladder cancer presenting to a tertiary referral center.
    Guzzo TJ; Hockenberry MS; Mucksavage P; Bivalacqua TJ; Schoenberg MP
    Urology; 2012 Jan; 79(1):166-71. PubMed ID: 22030373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smoking Behaviors and Prognosis in Patients With Non-Muscle-Invasive Bladder Cancer in the Be-Well Study.
    Kwan ML; Haque R; Young-Wolff KC; Lee VS; Roh JM; Ergas IJ; Wang Z; Cannavale KL; Ambrosone CB; Loo RK; Aaronson DS; Quesenberry CP; Kushi LH; Tang L
    JAMA Netw Open; 2022 Nov; 5(11):e2244430. PubMed ID: 36449286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smoking and smoking cessation effects on oncological outcomes in nonmuscle invasive bladder cancer.
    Simonis K; Shariat SF; Rink M;
    Curr Opin Urol; 2014 Sep; 24(5):492-9. PubMed ID: 24887046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of smoking status and recurrence of non-muscle invasive bladder cancer among patients managed with blue light cystoscopy.
    Matulewicz RS; Ravvaz K; Weissert JA; Porten S; Steinberg GD;
    Urol Oncol; 2021 Dec; 39(12):833.e19-833.e26. PubMed ID: 34053856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of smoking and smoking cessation on oncologic outcomes in primary non-muscle-invasive bladder cancer.
    Rink M; Furberg H; Zabor EC; Xylinas E; Babjuk M; Pycha A; Lotan Y; Karakiewicz PI; Novara G; Robinson BD; Montorsi F; Chun FK; Scherr DS; Shariat SF
    Eur Urol; 2013 Apr; 63(4):724-32. PubMed ID: 22925575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stopping smoking might reduce tumour recurrence in nonmuscle-invasive bladder cancer.
    Chen CH; Shun CT; Huang KH; Huang CY; Tsai YC; Yu HJ; Pu YS
    BJU Int; 2007 Aug; 100(2):281-6; discussion 286. PubMed ID: 17419696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Smoking Cessation after Bladder Cancer Diagnosis].
    Mota P; Sousa PM; Botelho F; Carvalho-Dias E; Cordeiro A; Torres JP; Morais N; Anacleto S; Lima E
    Acta Med Port; 2018 Feb; 31(2):101-108. PubMed ID: 29596769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of bladder cancer incidence and recurrence: tobacco use.
    Soria F; Marra G; Čapoun O; Soukup V; Gontero P
    Curr Opin Urol; 2018 Jan; 28(1):80-87. PubMed ID: 28984720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of smoking and smoking cessation on outcomes in bladder cancer patients treated with radical cystectomy.
    Rink M; Zabor EC; Furberg H; Xylinas E; Ehdaie B; Novara G; Babjuk M; Pycha A; Lotan Y; Trinh QD; Chun FK; Lee RK; Karakiewicz PI; Fisch M; Robinson BD; Scherr DS; Shariat SF
    Eur Urol; 2013 Sep; 64(3):456-64. PubMed ID: 23206854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of smoking on outcomes of patients with a history of recurrent nonmuscle invasive bladder cancer.
    Rink M; Xylinas E; Babjuk M; Hansen J; Pycha A; Comploj E; Lotan Y; Sun M; Karakiewicz PI; Abdennabi J; Fajkovic H; Loidl W; Chun FK; Fisch M; Scherr DS; Shariat SF
    J Urol; 2012 Dec; 188(6):2120-7. PubMed ID: 23083868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Educational opportunities in bladder cancer: increasing cystoscopic adherence and the availability of smoking-cessation programs.
    Kowalkowski MA; Goltz HH; Petersen NJ; Amiel GE; Lerner SP; Latini DM
    J Cancer Educ; 2014 Dec; 29(4):739-45. PubMed ID: 24719024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II Drug-Metabolizing Polymorphisms and Smoking Predict Recurrence of Non-Muscle-Invasive Bladder Cancer: A Gene-Smoking Interaction.
    Lacombe L; Fradet V; Lévesque É; Pouliot F; Larue H; Bergeron A; Hovington H; Caron A; Nguile-Makao M; Harvey M; Fradet Y; Guillemette C
    Cancer Prev Res (Phila); 2016 Feb; 9(2):189-95. PubMed ID: 26645279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low awareness, adherence, and practice but positive attitudes regarding lifestyle recommendations among non-muscle-invasive bladder cancer patients.
    Westhoff E; Kampman E; Aben KK; Hendriks IG; Witjes JA; Kiemeney LA; Vrieling A
    Urol Oncol; 2019 Sep; 37(9):573.e1-573.e8. PubMed ID: 31076356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The causal role of cigarette smoking in bladder cancer initiation and progression, and the role of urologists in smoking cessation.
    Strope SA; Montie JE
    J Urol; 2008 Jul; 180(1):31-7; discussion 37. PubMed ID: 18485400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.